@idk4sure.bsky.social
The rise of controllable, epigenetic therapies isn’t just science—it’s the next strategic frontier in biotech.
#Biotech #Epigenetics #GeneTherapy #PharmaInnovation #VC #PrecisionMedicine
#Biotech #Epigenetics #GeneTherapy #PharmaInnovation #VC #PrecisionMedicine
Epicrispr Biotechnologies Doses First Patient in First-in-Human Clinical Trial of EPI-321 for Facioscapulohumeral Muscular Dystrophy - Epicrispr Biotechnologies
- EPI-321 is the first investigational therapy designed to silence DUX4 expression via epigenetic modulation - FDA has granted Fast Track, Rare Pediatric
epicrispr.com
October 27, 2025 at 1:58 PM
The rise of controllable, epigenetic therapies isn’t just science—it’s the next strategic frontier in biotech.
#Biotech #Epigenetics #GeneTherapy #PharmaInnovation #VC #PrecisionMedicine
#Biotech #Epigenetics #GeneTherapy #PharmaInnovation #VC #PrecisionMedicine